Back to companies
BioRestorative Therapies, Inc.
BRTXUSNASDAQPharmaceuticals & HealthcareBioRestorative Therapies, Inc.
Revenue
$359,700
YoY -10.3%
Operating income
-$15.6mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API